Biological sciences
Immunology
Microbiology
Molecular biology
Journal
iScience
ISSN: 2589-0042
Titre abrégé: iScience
Pays: United States
ID NLM: 101724038
Informations de publication
Date de publication:
16 Jun 2023
16 Jun 2023
Historique:
received:
06
09
2022
revised:
24
04
2023
accepted:
09
05
2023
medline:
30
5
2023
pubmed:
30
5
2023
entrez:
30
5
2023
Statut:
ppublish
Résumé
The COVID-19 pandemic posed a global health crisis, with new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants weakening vaccine-driven protection. Trained immunity could help tackle COVID-19 disease. Our objective was to analyze whether heat-killed
Identifiants
pubmed: 37250788
doi: 10.1016/j.isci.2023.106873
pii: S2589-0042(23)00950-1
pmc: PMC10182650
doi:
Types de publication
Journal Article
Langues
eng
Pagination
106873Informations de copyright
© 2023 The Authors.
Déclaration de conflit d'intérêts
P-JC and CV are founders of Manremyc, the “Spin-off” of the Germans Trias i Pujol Research Institute (IGTP) that is developing the use of Nyaditum resae in collaboration with Reig Jofre SA. P-JC was also the CEO/CSO of Manremyc. P-JC and CV are the inventors of this food supplement. The MANRECOVID19 clinical trial was sponsored by the Reig Jofre Group, which had no role in the study design or data collection and analysis, decision to publish, or preparation of the manuscript. All authors had full access to all the data in the study and had final responsibility for the decision to submit for publication.
Références
Cell. 2018 Nov 29;175(6):1634-1650.e17
pubmed: 30433869
PLoS One. 2017 Feb 9;12(2):e0171294
pubmed: 28182700
Immunol Med. 2022 Dec;45(4):225-237
pubmed: 35491898
Vaccines (Basel). 2022 Feb 17;10(2):
pubmed: 35214772
Annu Rev Immunol. 2019 Apr 26;37:439-456
pubmed: 31026415
Front Immunol. 2022 Jan 24;12:748303
pubmed: 35140704
Infect Immun. 1985 Dec;50(3):938-40
pubmed: 4066040
N Engl J Med. 2021 May 20;384(20):1885-1898
pubmed: 33725432
J Leukoc Biol. 2015 Dec;98(6):995-1001
pubmed: 26082519
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Mem Inst Oswaldo Cruz. 2005 Aug;100(5):459-65
pubmed: 16184220
J Immunol. 2000 Jul 15;165(2):618-22
pubmed: 10878331
EClinicalMedicine. 2022 Jun;48:101414
pubmed: 35582122
Trials. 2020 Oct 26;21(1):881
pubmed: 33106170
Infect Immun. 2003 Apr;71(4):1755-62
pubmed: 12654789
Cell. 2021 Jun 24;184(13):3426-3437.e8
pubmed: 33991487
Clin Diagn Lab Immunol. 2000 May;7(3):352-9
pubmed: 10799445
Science. 2021 Aug 6;373(6555):648-654
pubmed: 34210893
J Infect Dis. 2015 Dec 15;212(12):1930-8
pubmed: 26071565
Vaccine. 2005 Jan 26;23(10):1251-7
pubmed: 15652667
Clin Infect Dis. 2000 Sep;31 Suppl 3:S64-7
pubmed: 11010824
PLoS Pathog. 2020 Apr 2;16(4):e1008404
pubmed: 32240273
EFSA J. 2019 Nov 11;17(11):e05824
pubmed: 32626149
Trials. 2020 Sep 17;21(1):799
pubmed: 32943115
Cell Host Microbe. 2018 Jan 10;23(1):89-100.e5
pubmed: 29324233
Nat Rev Microbiol. 2020 Jan;18(1):47-59
pubmed: 31728063
Annu Rev Immunol. 2021 Apr 26;39:667-693
pubmed: 33637018
Lancet Infect Dis. 2006 Mar;6(3):162-70
pubmed: 16500597
J Clin Invest. 2020 Dec 1;130(12):6290-6300
pubmed: 32784290
BMJ. 2014 Aug 05;349:g4643
pubmed: 25097193
J Immunol. 2002 May 1;168(9):4272-6
pubmed: 11970966
Front Microbiol. 2020 Mar 11;11:332
pubmed: 32218774
FEMS Microbiol Rev. 2018 Sep 1;42(5):656-671
pubmed: 29893825
Clin Transl Immunology. 2022 Apr 22;11(4):e1387
pubmed: 35573165
Proc Natl Acad Sci U S A. 2009 Dec 22;106(51):21660-5
pubmed: 19995986
Vaccines (Basel). 2021 Jul 06;9(7):
pubmed: 34358167
Virol J. 2015 Apr 14;12:61
pubmed: 26021751
J Med Virol. 2022 Mar;94(3):869-877
pubmed: 34672376
Genome Announc. 2015 Feb 05;3(1):
pubmed: 25657273
Immunol Cell Biol. 2017 Aug;95(7):601-610
pubmed: 28228641
Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2426-31
pubmed: 12606720
Front Immunol. 2018 Nov 30;9:2818
pubmed: 30555483
Front Pharmacol. 2021 Mar 25;12:646676
pubmed: 33841165
Nat Commun. 2019 Feb 20;10(1):874
pubmed: 30787276
Front Microbiol. 2016 Jan 05;6:1482
pubmed: 26779140
Nat Rev Immunol. 2020 Jun;20(6):375-388
pubmed: 32132681
Front Immunol. 2022 Mar 22;13:841868
pubmed: 35392074
Pathog Glob Health. 2017 Jul;111(5):256-264
pubmed: 28715935
Cell. 2021 Apr 29;184(9):2348-2361.e6
pubmed: 33730597
Front Immunol. 2022 Jul 05;13:873067
pubmed: 35865520
J Immunol Methods. 2014 Jan 15;402(1-2):76-81
pubmed: 24269601
Ann Rheum Dis. 2016 Apr;75(4):755-62
pubmed: 25649144
J Immunol Methods. 2003 Jul;278(1-2):145-55
pubmed: 12957403
Front Immunol. 2021 Feb 26;12:627548
pubmed: 33777012
J Clin Invest. 2023 Jan 17;133(2):
pubmed: 36282571
Nat Commun. 2019 Dec 11;10(1):5670
pubmed: 31827093
Clin Infect Dis. 2015 Jun 1;60(11):1611-9
pubmed: 25725054
J Infect Dis. 2018 Jul 24;218(5):679-687
pubmed: 29635431
Clin Immunol. 2018 Mar;188:103-112
pubmed: 29330114
Nat Microbiol. 2020 Apr;5(4):536-544
pubmed: 32123347
Clin Diagn Lab Immunol. 2000 Sep;7(5):759-63
pubmed: 10973450
Cardiovasc Res. 2021 Jan 1;117(1):224-239
pubmed: 33188677
Acta Med Indones. 2011 Jul;43(3):185-90
pubmed: 21979284
Epigenetics. 2020 Jun - Jul;15(6-7):765-779
pubmed: 32041475
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
BMC Immunol. 2006 May 25;7:11
pubmed: 16725038
BMJ Open. 2021 Oct 28;11(10):e052101
pubmed: 34711598
Proc Natl Acad Sci U S A. 2012 Oct 23;109(43):17537-42
pubmed: 22988082
Cytometry A. 2020 Sep;97(9):887-890
pubmed: 32654350
J Leukoc Biol. 2016 Nov;100(5):865-879
pubmed: 27605211
J Virol Methods. 2004 Oct;121(1):85-91
pubmed: 15350737
J Immunol. 2001 Aug 1;167(3):1245-53
pubmed: 11466340
Eur J Immunol. 2003 Jan;33(1):215-23
pubmed: 12594850
J Immunol. 2002 Sep 1;169(5):2756-61
pubmed: 12193750
Clin Vaccine Immunol. 2016 Dec 5;23(12):926-933
pubmed: 27733422
Cell. 2020 Oct 15;183(2):315-323.e9
pubmed: 32941801
J Exp Med. 2022 Feb 7;219(2):
pubmed: 34889942
Clin Diagn Lab Immunol. 1998 Nov;5(6):804-7
pubmed: 9801338
Inflammation. 2020 Aug;43(4):1323-1336
pubmed: 32170601
Trials. 2020 Jun 05;21(1):481
pubmed: 32503602